Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Improved candidate drug mining for Alzheimer's disease.

BioMed research international - 1 Jan 2014

Cheng Yu-Huei, Chuang Li-Yeh, Chang Hsueh-Wei, Yang Cheng-Hong

Abstract excerpt

Alzheimer's disease (AD) is the main cause of dementia for older people. Although several antidementia drugs such as donepezil, rivastigmine, galantamine, and memantine have been developed, the effectiveness of AD drug therapy is still far from satisfactory. Recently, the single nucleotide polymorphisms (SNPs) have been chosen as one of the personalized medicine markers. Many pharmacogenomics databases have been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Data Mining
Share to Databases, Factual

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 24719894
DOI: 10.1155/2014/897653
PMCID: PMC3955684

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Improved candidate drug mining for Alzheimer's disease.PMID 24719894Read ↗

Artificial intelligence for drug discovery and development in Alzheimer's diseaseSemantic proximity Read ↗

Recent Applications of Bioinformatics in Target Identification and Drug Discovery for Alzheimer’s DiseaseSemantic proximity Read ↗

AI-based mining of biomedical literature: Applications for drug repurposing for the treatment of dementiaSemantic proximity Read ↗

AI-based mining of biomedical literature: Applications for drug repurposing for the treatment of dementiaSemantic proximity Read ↗

Integrating network, sequence and functional features using machine learning approaches towards identification of novel Alzheimer genes.Semantic proximity Read ↗

Identifying Unexpected Therapeutic Targets via Chemical-Protein InteractomeSemantic proximity Read ↗

Mining drug-disease relationships as a complement to medical genetics-based drug repositioning: Where a recommendation system meets genome-wide association studies.Semantic proximity Read ↗

β-Secretase-1: In Silico Drug Reposition for Alzheimer’s DiseaseSemantic proximity Read ↗

Predicting the disease of Alzheimer with SNP biomarkers and clinical data using data mining classification approach: decision tree.Semantic proximity Read ↗

A novel approach for the identification of single nucleotide polymorphisms.Semantic proximity Read ↗

Identifying Novel Candidates for Re-Purposing as Potential Therapeutic Agents for Alzheimer’s diseaseSemantic proximity Read ↗

Impact of the CYP2D6 single nucleotide polymorphism on the concentration of and therapeutic response to donepezil in mild-to-moderate Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.